FDA.reportPublic FDA data

YASMIN 28 Day Pack

RxCUI
748857
RxNorm name
YASMIN 28 Day Pack
Display name
YASMIN 28 Day Pack
Full name
YASMIN 28 Day Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YasminDROSPIRENONE AND ETHINYL ESTRADIOLBayer HealthCare Pharmaceuticals Inc.d7ea6a60-5a56-4f81-b206-9b27b7e588752023-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 748857

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d7ea6a60-5a56-4f81-b206-9b27b7e58875YASMIN 28 Day PackPSN21These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120230519
d7ea6a60-5a56-4f81-b206-9b27b7e58875Yasmin 28 Day PackSY21These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120230519
d7ea6a60-5a56-4f81-b206-9b27b7e58875{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Yasmin 28 Day]BPCK21These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120230519
96af95c4-ed8b-450b-920b-bc12678f3584{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Yasmin 28 Day]BPCK2These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120120315
96af95c4-ed8b-450b-920b-bc12678f3584Yasmin 28 Day PackSY2These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120120315
96af95c4-ed8b-450b-920b-bc12678f3584YASMIN 28 Day PackPSN2These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120120315
bc2be936-aa7e-4eb2-868d-a65970d85b79YASMIN 28 Day PackPSN1These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120160128
bc2be936-aa7e-4eb2-868d-a65970d85b79Yasmin 28 Day PackSY1These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120160128
bc2be936-aa7e-4eb2-868d-a65970d85b79{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Yasmin 28 Day]BPCK1These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120160128